Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic Immune Thrombocytopenia

NCT05369208 is registered in ClinicalTrials.gov with Sobi, Inc. as lead sponsor.

NCT NCT05369208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05369208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic Immune Thrombocytopenia
Lead sponsor
Sobi, Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 15, 2022
Completion date
October 29, 2025
Enrollment
19 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

immune thrombocytopenia